AIDX
insider transactions20/20 Biolabs, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Alan B. Bergman KEY
Chief Financial Officer
$0
100.0K sh
Own New
-
Grant·A
Chief Operating Officer
$0
150.0K sh
Own New
-
Grant·A
Jonathan M Cohen KEY
Chief Executive Officer
$0
352.9K sh
Own New
-
Exercise·C
Director
—
6.1K sh
Own New
-
Exercise·C
Director
—
13.0K sh
Own New
-
Exercise·C
Director
$0
6.1K sh
Own +25%
-
Exercise·C
Director
$0
13.0K sh
Own +117%
-
Exercise·C
Director
—
31 sh
Own New
-
Exercise·C
Director
$0
31 sh
Own New
-
Exercise·C
Director
—
7.7K sh
Own New
-
Exercise·C
Director
$0
7.7K sh
Own +115%
-
Exercise·C
Director
—
7.7K sh
Own New
-
Exercise·C
Director
$0
7.7K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Apr 2, 2026 | Alan B. Bergman KEY | Grant A | 100.0K | $0 |
| Apr 2, 2026 | Jiming Zhou | Grant A | 150.0K | $0 |
| Mar 3, 2026 | Jonathan M Cohen KEY | Grant A | 352.9K | $0 |
| Feb 19, 2026 | John Woodson Rollins | Exercise C | 6.1K | — |
| Feb 19, 2026 | John Woodson Rollins | Exercise C | 13.0K | — |
| Feb 19, 2026 | John Woodson Rollins | Exercise C | 6.1K | $0 |
| Feb 19, 2026 | John Woodson Rollins | Exercise C | 13.0K | $0 |
| Feb 19, 2026 | Michael A. Ross | Exercise C | 31 | — |
| Feb 19, 2026 | Michael A. Ross | Exercise C | 31 | $0 |
| Feb 19, 2026 | John G. Compton | Exercise C | 7.7K | — |
| Feb 19, 2026 | John G. Compton | Exercise C | 7.7K | $0 |
| Feb 19, 2026 | COHEN RICHARD M | Exercise C | 7.7K | — |
| Feb 19, 2026 | COHEN RICHARD M | Exercise C | 7.7K | $0 |
About AIDX insider trading
This page tracks insider transactions for 20/20 Biolabs, Inc. (AIDX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.